Follow the OXURION share price and the full directors' dealings record of the company, a listed equity based in Belgium. Shares are listed on BE BE, under the authority of FSMA. The latest transaction was reported on 10 March 2022 (Purchase). Among the most active insiders: ECP LIQUID FUND 1 LLC. All data is accessible without an account.
3
Insider Decl.
0
Thresholds
€3m
2 ops.
Buy Volume
·
0 ops.
Sell Volume
15Σ signal
Buys €3m· Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2,766,337 shares@ €2.03100.0% of flowShareOff exchangeFSMA:oxurion-0
3 of 3 declarations
About OXURION
OXURION is a Belgian biopharmaceutical company focused on developing treatments for eye diseases. It aims to provide innovative therapies to improve patients' vision.